Physician profile
David Major
NPI 1801897251
$1,894.42
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,708 · 2020: $186.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $331.06 | 2019-2020 | |
| Astellas Pharma US INC | $237.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $233.21 | 2019-2020 | |
| Amarin Pharma, INC. | $206.63 | 2019-2020 | |
| Lilly USA, LLC | $185.99 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.92 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.26 | 2019 | |
| Pfizer INC. | $73.84 | 2019 | |
| Sanofi Pasteur INC. | $54.92 | 2019-2020 | |
| Glaxosmithkline, LLC. | $48.84 | 2019 | |
| Gilead Sciences, INC. | $47.66 | 2019 | |
| Radius Health, INC. | $46.62 | 2019 | |
| Merck Sharp & Dohme LLC | $42.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.98 | 2019 | |
| Amgen INC. | $37.77 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $30.18 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.08 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $21.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.34 | 2019 | |
| Shire North American Group INC | $14.95 | 2019 | |
| Seqirus USA INC | $12.78 | 2019 | |
| Allergan, INC. | $12.49 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Major listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.